Toxic epidermal necrolysis after allogeneic hematopoietic stem cell transplantation for refractory Hodgkin’s lymphoma.

Karolina Chromik, Aleksandra Spyra, Paulina Repa, Grzegorz Helbig

Vol 55, No 4 (2024)

Clinical vignette

Hematological aberrations in patient with Jacobsen syndrome

Agnieszka Jatczak-Gaca

Vol 54, No 5 (2023)

Clinical vignette

Use of vedolizumab in children with steroid-refractory gastro-intestinal graft-versus-host disease

Joanna Cisek, Anna Dąbrowska, Agnieszka Majk, Krzysztof Czyżewski

Vol 55, No 5 (2024)

Short communication

Treatment options for anaemia in myelofibrosis

Aleksandra Gołos, Joanna Góra-Tybor

Vol 55, No 6 (2024)

Review article

Checkpoint inhibitors as potential therapeutics in acute myeloid leukemia

Krzysztof Bieliński, Bartosz Puła, Łukasz Bołkun

Vol 55, No 6 (2024)

Review article

Hematology and transfusion medicine journal of pediatric and adult diseases: we all are readers, authors and reviewers

Jan Styczyński

Vol 54, No 5 (2023)

Editorial

Sudden central vision loss in a young patient with chronic myeloid leukemia

Marcin Jasiński, Przemysław Krajewski, Małgorzata Paszkowska-Kowalewska, Krzysztof Jamroziak

Vol 55, No 5 (2024)

Clinical vignette

Mutations of variable parts of immunoglobulin heavy chains (IGHV) — assay methodology and recommendations on how to report results

Magdalena Zawada, Marzena Wojtaszewska, Sylwia Czekalska, Paulina Własiuk

Vol 55, No 6 (2024)

Guidelines / Expert consensus

Endothelial dysfunction and thrombosis in polycythemia vera

Weronika Marzena Lebowa, Patrycja Lebowa, Tomasz Sacha

Vol 55, No 6 (2024)

Review article

Recommendations for management in diagnostics and therapy in herpesviruses infections in children with malignancy or after hematopoietic cell transplantation

Krzysztof Czyżewski, Agnieszka Sobkowiak-Sobierajska, Anna Pieczonka, Maksymilian Deręgowski, Jacek Wachowiak, Katarzyna Derwich, Krzysztof Kałwak, Katarzyna Drabko, Jolanta Goździk, Iwona Malinowska, Paweł Łaguna, Jan Styczyński

Vol 56, No 1 (2025)

Guidelines / Expert consensus

Acute promyelocytic leukemia in patient with chronic myeloid leukemia treated with tyrosine kinase inhibitors

Agnieszka Brzozowska, Natalia Bujko-Wasiak, Yuliia Konieva, Wiesław Wiktor Jędrzejczak, Katarzyna Brzeźniakiewicz-Janus

Vol 55, No 6 (2024)

Clinical vignette

Relationship between reticular fibrosis with platelet surface markers (CD41A, CD42A, CD42B, CD61) and prognostic markers (WBC, PLT) in acute promyelocytic leukemia

Ahmet Kaya, Mehmet Ali Erkurt, Irfan Kuku, Emin Kaya, Ilhami Berber, Ahmet Sarıcı, Zehra Bozdağ, Soykan Biçim, Süleyman Arslan, Fatma Hilal Yagın

Vol 55, No 5 (2024)

Original research article

Cladribine — still important in era of new therapies

Bartosz Puła

Vol 55, No 5 (2024)

Editorial

Mutation status of immunoglobulin variable heavy chain genes (IGHV) — from immunological curiosity to forefront of diagnostics in chronic lymphocytic leukaemia

Tomasz Stokłosa

Vol 55, No 6 (2024)

Editorial

Benefits of infusion pump technology in treatment of patients with acquired hemophilia A and hemophilia A with inhibitor a Polish pilot observational study

Michal Witkowski, Wiktoria Ryżewska, Tadeusz Robak

Vol 55, No 6 (2024)

Original research article